Envestnet Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,016
Closed -$235K 4293
2024
Q1
$235K Buy
+8,016
New +$256K ﹤0.01% 3862
2019
Q4
Sell
-5,530
Closed -$253K 3151
2019
Q3
$253K Buy
5,530
+757
+16% +$33K ﹤0.01% 2755
2019
Q2
$206K Buy
+4,773
New +$201K ﹤0.01% 2873

Other funds holding SRDX

Envestnet Asset Management's SRDX Position: Q2 2024 in Review

Envestnet Asset Management sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 8,016 shares — an estimated $235K sold.

Envestnet Asset Management first reported a position in SRDX in Q2 2019 and held it in 3 quarters. The position peaked at $253K in Q3 2019. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Envestnet Asset Management reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 8,016 Surmodics shares in Q2 2024, an estimated $235K.
  • Envestnet Asset Management first reported a position in Surmodics in Q2 2019 and held it in 3 quarters.
  • Envestnet Asset Management's Surmodics position peaked at $253K in Q3 2019.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Envestnet Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.